尽管该公司损失了收入估计数并报告了损失,但SightScience的EVP购买了更多的股票。 EVP of Sight Sciences bought more stock despite the company missing revenue estimates and reporting a loss.

视力科学公司EVP Manohar K. Raheja最近购买了更多的公司股票,增加了他的股份。 EVP of Sight Sciences, Inc. Manohar K. Raheja recently bought more company stock, increasing his holdings. 该公司每季度每股损失22美元,收入2 016万美元,缺少分析师的估计。 The company had a quarterly loss of $0.22 per share and revenue of $20.16 million, missing analyst estimates. 视力科学是眼科医疗设备,市场上限为1.8779亿美元,公平回报为负值。 Sight Sciences, which makes ophthalmic medical devices, has a market cap of $187.79 million and a negative return on equity. 尽管降级,但股票的“持股”评级为5.50美元的目标价格。 Despite downgrades, the stock has a "hold" rating with a $5.50 target price. 机构投资者也一直在改变其在公司中的股权。 Institutional investors have also been modifying their stakes in the company.